Company news
Vistagen Therapeutics, Inc. news in 2021
Vistagen Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
VistaGen Therapeutics Reports Fiscal Year 2022 Second Quarter Financial Results and Provides Corporate Update
November 9, 2021
VistaGen Therapeutics to Report Fiscal Year 2022 Second Quarter Financial Results and Recent Developments on November 10, 2021
November 3, 2021
VistaGen Therapeutics Expands Clinical Development of PH94B with Initiation of Phase 2A Trial in Adjustment Disorder
October 13, 2021
VistaGen Therapeutics Reports New Preclinical Mechanism of Action Data Supporting PH94B’s Potential Anti-Anxiety Activity via Peripheral Nasal Neurons without Entry into the Brain
October 4, 2021
VistaGen Therapeutics Further Advances PALISADE Phase 3 Program for PH94B in Social Anxiety Disorder with Initiation of PALISADE-2
September 12, 2021
VistaGen Therapeutics Reports Fiscal Year 2022 First Quarter Financial Results and Provides Corporate Update
August 11, 2021
VistaGen Therapeutics Announces Appointment of Maggie FitzPatrick to its Board of Directors
July 21, 2021
VistaGen Therapeutics Announces Appointment of Mary L. Rotunno to its Board of Directors
July 6, 2021
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
June 28, 2021
VistaGen Therapeutics to Report 2021 Fiscal Year End Financial Results, Provide a Business Update and Host Conference Call and Webcast June 29, 2021
June 24, 2021
VistaGen Therapeutics Initiates PALISADE Phase 3 Trial of PH94B in Social Anxiety Disorder
May 25, 2021
VistaGen Therapeutics Announces Appointment of Ann Cunningham as Chief Commercial Officer
May 3, 2021
VistaGen Therapeutics Announces Appointment of Joanne Curley, Ph.D. to its Board of Directors
April 26, 2021
VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021
February 10, 2021
VistaGen Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
January 5, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (August 2021)
Investor deck · 34 slides · Aug 12, 2021
- Investor Presentation (June 2021)
Investor deck · 34 slides · Jun 15, 2021